Search results
FDA Delays Decision on Sanofi (SNY)-Regeneron Dupixent in COPD
Zacks via Yahoo Finance· 5 days agoPer the FDA, the data submitted by Sanofi (SNY)/Regeneron (REGN) for Dupixent in COPD indication...
GSK shares fall 9% in wake of Zantac court ruling
Pharmaceutical Technology via Yahoo Finance· 18 hours agoIn 2022, the judge in the MDL case referenced by GSK, which also implicated Pfizer, Sanofi and Boehringer Ingleheim, rejected the prospect of a full...
GSK Plunges as Drugmaker Must Face Zantac Cases in Delaware
Bloomberg via Yahoo Finance· 2 days ago(Bloomberg) -- GSK Plc shares plunged in the wake of a court ruling that the UK drugmaker, alongside...
Sanofi's Dupixent Drug Review Date Extended by Three Months in the U.S.
Market Watch· 5 days agoFrench pharmaceutical company Sanofi said that the priority review date in the U.S. for its chronic obstructive pulmonary disease treatment, Dupixent has ...
EMA backs approving Sanofi's Dupixent for 'smoker's lungs', FDA extends review
Reuters via Yahoo News· 5 days agoFrench drugmaker Sanofi and its U.S. partner have been counting on expanding the use of the drug as...
TEVA Stock Rises 135% in a Year: What's Driving the Recovery?
Zacks via Yahoo Finance· 12 hours agoZacks Rank Teva currently has a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks...
French pharma Sanofi announces stock purchase plan for employees
dpa international via Yahoo Finance· 5 days agoFrench pharmaceutical firm Sanofi has announced its stock purchase plan for employees for this year....
Navigating 14 Analyst Ratings For Regeneron Pharmaceuticals - Regeneron Pharmaceuticals...
Benzinga· 15 hours agoPharmaceuticals analyst ratings. About Regeneron Pharmaceuticals Regeneron Pharmaceuticals discovers, develops, and commercializes products ...
France against Servier selling generics unit Biogaran, PM says
Reuters via AOL· 7 days agoPARIS (Reuters) -The French government has told drugmaker Servier it is against any sale of its...
Sanofi’s CEO thinks OpenAI offers 'insane' potential for thepharmaceutical industry
Fortune· 7 days agoIf generative AI is going to be more than hype and hallucinations, the trillion-dollar pharma industry is where the magic may happen. Last week, Hudson proudly announced his company’s new partnership ...
